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Purpose: To determine the percentage of patients implanted bilaterally with ReSTOR® requiring 
spectacles at 18 months, the patient satisfaction, and factors that predict spectacles independence.
Methods: The medical and surgical data were collected from patient records. The ‘Freedom 
from Spectacles Value Scale’ (FGVS) was used to rank their experiences via telephone interview. 
A Bayesian network was used to predict postoperative spectacles use.
Results: 304 patients (65.6 years) were included. Postoperative visual acuity was 0.8 in 93.3% 
of patients for near vision and in 88.6% of patients for distance vision. After surgery, 87.2% of the 
patients were spectacles free. 88.2% of the patients rated their vision as being better following the 
surgery and 93.1% thought that surgery resulted in a positive change. FGVS mean scores (5 the most 
favorable rating) were: ‘Practical Advantages’ 3.8, ‘Psychological Advantages’ 3.8, ‘Evaluation 
of the Result’ 4.5, ‘Feelings’ 4.4, and ‘Global Judgement’ 4.4. Patients who stated that spectacles 
wear was particularly bothersome and those who thought that their appearance was more favorable 
without spectacles were 3 times more likely not to wear spectacles postoperatively.
Conclusion: ReSTOR® provides patients with good distance and near vision, a high rate of 
spectacles independence, and a high degree of patient satisfaction.
Keywords: cataract surgery, multifocal intraocular lens, patient satisfaction, spectacles 
independence
Introduction
The restoration of functional distance and near vision, independent of any additional 
refractive correction, remains an ultimate goal for many cataract surgeons. Multifocal 
intraocular lenses (IOLs) use the principle of simultaneous vision to allow functional 
vision at all distances.1 Clinical experience with multifocal IOLs show that they do, 
indeed, provide patients with the ability to see without spectacles at all distances with 
an acceptable level of satisfaction.2
The AcrySof® ReSTOR® multifocal intraocular lens is a foldable, single-piece, 
biconvex IOL made of a soft acrylic material of high refractive index. The central 
part of its anterior surface comprises an apodized diffractive region that distributes 
light to allow a full range of vision.3 The efficacy and safety of the ReSTOR® IOL has 
been reported in numerous publications4–16 and has been shown to provide a lifelong, 
cost-effective alternative to spectacles.17,18
Health authorities now increasingly consider the impact on patient-reported out-
comes (PROs) and health-related quality of life (HRQoL) issues from both a clinical Clinical Ophthalmology 2010:4 82
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and economic perspective.19–22 Indeed, the replication and 
validation of results achieved in clinical trials is an impor-
tant public health issue when considering use of such prod-
ucts within the public sector. At the time of this study the 
ReSTOR® IOL had been available to the study surgeons for 
more than 2 years; several thousand IOLs had been success-
fully implanted and the clinical data of these patients were 
readily available in patient record files.
The aim of this study was three-fold: 1) to estimate 
the percentage of patients bilaterally implanted with the 
ReSTOR® IOL who remained dependent upon spectacles 
18 months postoperatively; 2) to determine the degree of 
satisfaction patients experienced with their IOLs, and 3) To 
identify the psychological factors most likely to predict 
postoperative spectacles independence.
Patients and methods
This cross-sectional, multicenter, noncomparative study 
was conducted in France and Spain, between June 2007 and 
January 2008. All procedures conformed to the tenets of The 
Declaration of Helsinki and were in accordance with the 
European Directive 2001/20/CE. No local Ethics Committee 
approval was required.
Patient inclusion
Centers were selected from each country in which surgeons 
were experienced ReSTOR® users and had implanted numer-
ous lenses in the preceding 18 months. All patients recruited 
had undergone bilateral cataract surgery and ReSTOR® 
implantation. At the time of the survey, SA60D3, SN60D3, 
and SN6AD3 were available for surgery.
Inclusion criteria specified that patients should be 
50 years old, were treated for bilateral presbyopia or age-
related cataract using phaco-emulsification and bilateral 
implantation of the ReSTOR® IOL resulting in postoperative 
emmetropia, and had at least 1 year elapse since the operation 
to the second eye.
Exclusion criteria included any patient implanted with 
the ReSTOR® IOL as part of a clinical trial, any surgical 
complications necessitating a refractive correction (refrac-
tive procedures during surgery were allowed), a postsurgi-
cal infection, any history of previous refractive surgery 
(ie, before ReSTOR® implantation), any ocular disease that 
might have seriously compromised visual acuity after cata-
ract surgery, a prognosis of deteriorating visual acuity, or an 
inability (eg, deafness or cognitive impairment) to engage 
personally in a telephone interview.
Patients meeting the inclusion criteria were selected 
randomly from an exhaustive list of cases. Letters were sent 
to each patient explaining the purpose of the research and 
requesting their participation. Agreement was made through 
the signing of an informed consent form and a subsequent 
telephone interview. All necessary medical data were col-
lected from the patient records.
The objective of the study was to survey a total of 
300 patients (30 patients from each center – 5 centers from 
France and 5 from Spain). Previous studies indicate that 
bilateral implantation of the ReSTOR® IOL results in at least 
80% of patients not needing spectacles 1 year postopera-
tively. Power analysis of the data indicated that a cohort of 
300 patients should provide sufficient power (95% confidence 
interval 75% to 85%) to estimate spectacles independence, 
the primary endpoint of this study.
Outcome measures
Medical data comprising socio-demographic variables (age, 
gender, job status), clinical characteristics before surgery 
(general and ocular co-morbidities), eye characteristics at 
surgery, and visual acuity (before and after surgery) were 
collected retrospectively from the patient medical records. 
Patient satisfaction and factors contributing to postoperative 
spectacles independence were assessed prospectively by a 
direct telephone interview. This interview covered aspects 
relating to the patient’s socio-occupational status, spectacles 
dependence before and after ReSTOR® IOL implantation, 
subjective evaluation of the quality of their postsurgical 
vision without spectacles, details on their private health insur-
ance coverage, and any change in their ocular and general 
health since surgery that may negatively affect the patient’s 
perspective of the performance of the lens.
Patient satisfaction was assessed using a new, specific 
21-item tool (‘Freedom from Spectacles Value Scale’: FGVS) 
that was administered during the telephone interview.23–26 
The FGVS includes ‘Global Evaluation’ and ‘Advantages’ 
dimensions that are self-rated from 1 (‘No, not at all’) to 
5 (‘Yes, absolutely’). The ‘Global Evaluation’ dimension 
includes three subdimensions (‘Evaluation of the Result’, 
‘Feelings’ and ‘Global Judgment’).  The ‘Advantages’ dimen-
sion has two subdimensions, ‘Practical Advantages’ and 
‘Psychological Advantages’, that ask questions relating to the 
benefits that freedom from spectacles offers. The ‘Practical 
Advantages’ subdimension covers the patient’s perception of 
how troublesome spectacles wear is, eg, ‘Do you find it is a 
bother to wear spectacles?’ rated from 1 (‘No, not at all’) to 5 
(‘Yes, absolutely’), with 5 being the most unfavorable score. Clinical Ophthalmology 2010:4 83
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Table 1 socio-demographic data
Country France Spain Total
n 152 152 304
sex (% male) 36.2 32.2 34.2
Age (year),
  Mean ± sD 64.9 ± 7.5 66.4 ± 8.9 65.6 ± 8.3
  Range 50.5 to 79.3 50.8 to 83.0 50.5 to 83.0
Retired patients (%) 77.0 63.2 70.1
Current job status or before retirement (%)
  Legislative, public administrative high grade profession, managers 6.6 13.2 9.9
  Intellectual and scientific profession 6.6 4.6 5.6
  intermediate-grade profession 13.8 31.6 22.7
  Administrative employees 31.6 4.0 17.8
  salesperson or services profession 7.9 0 3.9
  Farmers, forestry and fishing profession 4.6 0.4 2.6
  Artisans, craft workers 11.8 0.4 6.3
  Truck drivers, building site workers 2.6 0 1.3
  Non-qualified employees and workers 5.3 10.5 7.9
  Professional army 1.3 0 0.7
  Others jobs 7.9 34.9 21.4
Co-morbidities before surgery (%)
  Cardiovascular system 19.7 14.5 17.1
  Psychiatry 0.7 2.6 1.6
  Respiratory system 1.3 2.0 1.6
  skeleton and muscles 2.6 7.2 4.9
  Urogenital system 0.7 3.9 2.3
  Digestive system 1.3 2.0 1.6
  Cancer 1.3 0.7 1.0
  immune system 2.6 9.2 5.9
  enT (ear nose throat) 0 1.3 0.7
  Central nervous system 1.3 3.3 2.3
  skin and dermoskeleton 2.0 0 1.0
  Metabolic disorders 17.8 4.6 11.2
  Others 0.7 5.3 3.0
health care insurance coverage (%)
  Public health insurance only 25.0 42.8 33.9
  Public health insurance and private insurance 75.0 57.2 66.1
Other practical related questions included those pertaining 
to condensation, heaviness, movement on nose, restrictions 
in vision, cleaning, loss and breakage. The ‘Psychological 
Advantages’ subdimension includes items relating to ‘Self-
image’ and ‘Other people’s perceptions’, eg, ‘Do other people 
prefer your appearance without or with spectacles?’ rated 
from 1 (‘Definitely better without spectacles’) to 5 (‘Defi-
nitely better with spectacles’).
statistical analysis
Statistical analysis was performed using SASTM statistical 
software (SAS Institute; North Carolina, USA) for all patients 
enrolled. Comparisons across countries were performed using 
a Chi-square test for categorical variables and Student t-tests 
for continuous variables.
A Bayesian network was constructed to predict post-
operative spectacles use as specified from FGVS scores, age, 
sex and country. The network was constructed with Bayesi-
alab software, release 4.6.1 (Bayesia, Mayenne, France), that 
uses an unsupervised learning paradigm to reveal the entire 
set of probabilistic relationships existing within a database.
A Bayesian network is a probabilistic graphical model 
that represents a set of random variables and their conditional 
independencies via a directed acyclic graph. Our Bayesian Clinical Ophthalmology 2010:4 84
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Table 2 snellen decimal distance visual acuity of the best eye 
before surgery
Variable  France  
(n = 146)
Spain  
(n = 150)
Total  
(n = 296)
Visual acuity  
(decimal)
  Mean ± sD 0.85 ± 0.19 0.72 ± 0.25 0.78 ± 0.23
  Median 0.9 0.8 0.8
  Range 0.3 to 1.2 0.05 to 1.0 0.05 to 1.2
Patients  0.8 (%) 73.3 52.0 62.5
Notes: Distance visual acuity was not collected in 8 (France: 6; spain: 2) patient charts.
Table 3 Reason for surgery: cataract and/or presbyopia
Reason for surgery France Spain Total
n (%) 112 152 264 (100.0)
Cataract in both eyes 73 (65.2) 144 (94.7) 217 (82.2)
Presbyopia in both eyes 37 (33.0) 6 (3.9) 43 (16.3)
Cataract in one eye and 
presbyopia in other eye
2 (1.8) 2 (1.3) 4 (1.5)
not documented 40 – 40
network represents the probabilistic relationships between 
FGVS scores and spectacles independence. Given FGVS 
scores, the network can be used to compute the probability 
of wearing spectacles.
To estimate the Bayesian network we used the Taboo 
Order (using ‘Tabu Search’)27 algorithm. Taboo Order is a 
Bayesian network learning algorithm quantified by a ‘Mini-
mum Description Length’ (MDL) score.28
Results
socio-demographics data
A total of 490 eligible patients were selected and contacted 
from the randomized lists provided (France: 194; Spain: 296). 
Replies were received from 89% of the contacted individuals 
in France (161 positive: 94%) and 59% in Spain (163 posi-
tive: 94%). Successful follow-on telephone interviews were 
conducted with 155 individuals from France and 161 from 
Spain. From these patients full medical record analysis was 
carried out on 152 patients from each country for a total of 
304 patients.
The socio-demographic data are presented in Table 1. 
The mean age of patients was 65.6 ± 8.3 years with no sig-
nificant national differences. 70.1% of these patients were 
retired and the majority of them (65.8%) were female. Of 
those patients who are employed, 40.5% classed themselves 
as having administrative to intermediate-grade professional 
jobs. The most common co-morbidities were cardiovascular 
diseases (17.1%) and of the cohort examined, 66.1% had 
private health insurance.
Visual characteristics of patients  
before surgery
Prior to surgery, 28% of the patients were myopic, 68% were 
hypermetropic and 50% were astigmatic. The proportions of 
astigmatic and myopic patients were significantly higher in 
Spain (P  0.05), whereas the proportion of hypermetropic 
patients was significantly higher in France (P  0.05). Early 
glaucoma affected 3% of patients, and 2% had concomitant 
macular or optical nerve pathology with the potential to 
impair vision. Finally, 5.3% of patients received medication 
for ocular hypertension.
Table 2 provides details of the Snellen decimal distance 
visual acuity. Pre-operatively 62.5% of patients had a visual 
acuity of 0.8 or better and there was a statistically significant 
(P  0.05) differential between the countries, with more 
patients attaining this score in France (73.3%) than in Spain 
(52.0%).
surgical features
Table 3 indicated that the main motivating factor for 
ReSTOR® implantation was presence of cataract rather 
than presbyopia and this was especially true in Spain. The 
mean time interval between the first and second eye opera-
tions was approximately 15.7 days and the average time 
since the second eye operation to the time of this study was 
2.0 years. The mean power of the ReSTOR® IOL implanted 
was 21.1 D ± 3.6 D.
Visual characteristics of patients  
after surgery
In both countries more than 90% of patients did not undergo 
further refractive surgery following ReSTOR® implanta-
tion. Postoperative refraction results are given in Table 4. 
For near vision the mean uncorrected best eye visual acuity 
(decimal) was 0.96, while for distance vision the figure was 
0.90. Moreover, postoperative visual acuity was 0.8 for 
near vision in 93.3% of patients; for distance vision in the 
value was 88.6%.
spectacles independence
Prior to surgery 93.4% of patients wore spectacles; of these 
51.8% wore varifocal spectacles and 19.7% wore contact lenses. 
In addition, 45.1% of these patients reported replacing their 
spectacles every 3 years, or more, the frequency being higher in 
France than in Spain. Following surgery 87.2% of patients were Clinical Ophthalmology 2010:4 85
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spectacles free (France: 88.2%; Spain: 86.2%). Of those patients 
who wore spectacles postoperatively the majority did so only 
sometimes (61.5%) and in most cases (71.8%) for near vision.
subjective evaluation of postoperative 
spectacles independence
The Bayesian network based on FGVS scores, age, sex and 
country is presented in Figure 1. The network depicts associa-
tions (arrows) connecting subscores of ‘Global Evaluation’ 
ratings. ‘Global Judgment’, ‘Evaluation of the Result’, and 
‘Feelings’ subdimensions were excluded because of items 
confounded with ‘Global Evaluation’. Figure 1 shows that 
‘Global Evaluation’ (benefit) was associated with both 
practical and psychological benefits, as well as the patient’s 
self-image without spectacles.
More importantly, the Bayesian network evinced two 
factors that were strong predictors of postoperative spectacles 
independence. These were. 1) Do you find that it is a bother 
to wear spectacles?; and 2) Do other people prefer to see 
you with or without spectacles? Reports of ‘bother with 
Table 4 Best eye visual acuity after surgery
Variable France Spain Total
Near uncorrected visual acuity (decimal)
  Patients (n) 145 137 282
  Mean ± sD 1.01 ± 0.05 0.90 ± 0.19 0.96 ± 0.15
  Median 1.0 1.0 1.0
  Range 0.8 to 1.2 0.25 to 1.0 0.25 to 1.2
  Patients  0.8 (%) 100 86.1 93.3
Near best corrected visual acuity (decimal)
  Patients (n) 88 87 175
  Mean ± sD 1.00 ± 0.01 0.89 ± 0.21 0.95 ± 0.16
  Median 1.0 1.0 1.0
  Range 0.9 to 1.0 0.4 to 1.0 0.4 to 1.0
  Patients  0.8 (%) 100 79.3 89.7
Distance uncorrected visual acuity (decimal)
  Patients (n) 146 151 297
  Mean ± sD 0.91 ± 0.13 0.89 ± 0.13 0.90 ± 0.13
  Median 1.0 0.9 0.9
  Range 0.4 to 1.2 0.4 to 1.0 0.4 to 1.2
  Patients  0.8 (%) 89.7 87.4 88.6
Distance best corrected visual acuity (decimal)
  Patients (n) 99 94 193
  Mean ± sD 0.96 ± 0.08 0.96 ± 0.07 0.96 ± 0.07
  Median 1.0 1.0 1.0
  Range 0.7 to 1.0 0.8 to 1.0 0.7 to 1.0
  Patients  0.8 (%) 94.9 100 97.4
spectacles’ were associated with age, ‘Global Evaluation’ 
(benefit), and self-image without spectacles.
Figure 2 indicates the proportion of patients who were 
bothered by various inconveniences of wearing spectacles 
(condensation on lenses, cleaning, heaviness, slipping down 
nose, restricted vision, loss, damage, and breakage). Span-
ish patients were more troubled than French patients by the 
latter four items.
Patient satisfaction
Following surgery 93.1% of patients noted a global positive 
change in their vision, 88.2% stated their vision had improved, 
and 78.0% of patients considered their sight problems to be 
resolved. Mean scores from the FGVS tool (scaled 1 = bad 
to 5 = good?) were ‘Global Evaluation’ = 4.5. Mean sub-
scores were ‘Evaluation of the result’ = 4.5, ‘Feelings’ = 4.4, 
and ‘Global Judgment’ = 4.5, demonstrating high levels of 
satisfaction throughout the population. The ‘Advantages’ 
score was 3.8. Mean ‘Advantages’ subscores for spectacles 
freedom were ‘Practical’ = 3.8 and ‘Psychological’ = 3.8. Clinical Ophthalmology 2010:4 86
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Further analysis of the psychological score revealed that most 
patients (70.4%) preferred themselves without spectacles and 
50.7% reported that others, too, preferred their appearance 
without spectacles.
A subgroup of patients (n = 12) rated ‘bother to wear 
spectacles’ 5 (they did not answer ‘Yes, absolutely’ to the 
question ‘Do you find it is a bother to wear spectacles?’) 
and rated self-appearance with spectacles either 4 or 5 (they 
answered ‘Definitively or somewhat better without spectacles’ 
to the question ‘Do other people prefer the way you look with 
or without spectacles?’). Patients who showed little concern 
over wearing spectacles were more likely (probability: 58%) 
to wear them following ReSTOR implantation (Figure 3). 
The probability of wearing spectacles postoperatively in 
the total population was 12.8%. The foregoing 12 patients 
comprised 3.9% of the total population examined. Had they 
not been offered ReSTOR® lenses the proportion of patients 
who ultimately wore spectacles would have been reduced, 
resulting in an overall spectacles freedom rate of 89.0%. 
Conversely, Figure 3 shows that those patients who were 
considerably inconvenienced by spectacles and sensitive to 
the preference of others to see them without spectacles were 
three times more likely not to wear them postoperatively 
(probability: 22%).
Discussion
Several clinical trials have confirmed the efficacy and safety 
of the AcrySof® ReSTOR® IOL.4–15 The ReSTOR® IOL has 
Condensation on the spectacles
Spectacles are heavy on the nose
The fear of losing spectacles
The fear of damaging spectacles
The fear of breaking spectacles
The frames restrict the vision
Spectacles have to be constantly cleaned
Spectacles keep slipping down the nose
France 
Spain
Total
100%
80%
60%
40%
20%
0%
Figure 2 Disadvantages of wearing spectacles as self-rated by patients agreeing ‘strongly’ or ‘somewhat’ with the respective items.
Figure 1 Bayesian network. each node represents a variable. All continuous variables were dichotomized. each arrow describes an association between variables. each arrow 
is associated with a contingency table (available upon request). With the contingency table set, a posteriori probability could be evaluated. The a posteriori probability to wear 
spectacles knowing the answers to ‘Bother to wear spectacles’ and to ‘People prefer the way you look without spectacles’ are presented in Figure 3.
Wearing spectacles after surgery
People prefer the way you look without spectacles
Gender
Country
Psychological benefits
I prefer the way I look without spectacles
Age
Bother to wear spectacles
Practical benefits Global benefitsClinical Ophthalmology 2010:4 87
spectacle independence after resTOR implantation Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
demonstrated good near vision acuity without compromising 
distance vision, acceptable contrast sensitivity, thus leading 
to spectacles independence and high patient satisfaction, in 
most of the patients. To our knowledge no real-life study has 
been conducted to assess the psychological factors that best 
predict spectacles independence in bilateral ReSTOR® IOL 
cataract or presbyopia patients.
The objective of the present study was to address this 
question with an appropriate study design using a large sample 
of more than 300 patients in France and Spain, in order to 
assess the effectiveness of ReSTOR® IOL implantation 2 years 
postoperatively. The survey confirmed that uncorrected visual 
acuity dramatically improved from its presurgical state. For 
spectacles independence, 87.2% of patients (France: 88.2%; 
Spain: 86.2%) never wore spectacles following implantation 
of the lens for either near or distance vision. Moreover, the 
proportion increased to almost 90% of cases when 4% of 
the patient cohort, who expressed no particular interest in 
freedom from spectacles, was excluded from the analysis. 
A concordant finding was high patient satisfaction, 88.2% 
rating their vision as being better after surgery and 93.1% 
affirming that surgery had changed their vision positively.
The present observational findings mirror the results 
obtained through previous clinical trials that address freedom 
from spectacles wear following ReSTOR® implantation. For 
example, Chiam et al5,15 reported spectacles dependency 
in 14% to 15% of patients, while Vingolo et al29 reported 
8% and Sallet30 found 0%. A European multicenter study8 
of 117 patients reported that 74.4% never wore spectacles 
again after ReSTOR® implantation, with higher rates when 
distance vision (88.0%) and near vision (84.6%) were 
considered separately. Alfonso et al31 evaluated distance, 
intermediate, and near vision performance in 325 patients 
with ReSTOR® IOLs and at 6 months postoperatively found 
that 98% were free from spectacles for near vision and 96% 
for intermediate vision. Recently, De Vries et al32 reported 
a 3-year follow-up study of AcrySof® ReSTOR® implants 
in 22 cataract patients (44 eyes). Six months after surgery, 
83.7% of patients regained complete spectacles independence 
for distance vision and 81.9% for near vision. At 3 years 
these proportions were 85.0% and 75.0%, respectively, and 
patients expressed high satisfaction.
Freedom from spectacles is a major outcome variable 
for ReSTOR® IOL surgery, not only for overall patient 
satisfaction and quality of life, but also for spectacles costs 
for aging people with cataracts or presbyopia. The cost to 
patients for a pair of spectacles in four European Countries 
was recently estimated by Cuq et al33 at between €213 and 
€316, and from a societal perspective it varied from €214 to 
€566. Economic models applied to France, Germany, Italy 
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Figure 3 Probabilities of wearing spectacles according to the Bayesian network. A priori probability is presented by the dotted line and equals 12.8%. Vertical bars represent a 
posteriori probabilities, ie, once the answer to the question is known. The higher the distance between the dotted line and the vertical bar, the more informative the answer.
Questions:
People preference: Do other people prefer the way you look with or without spectacles? 1: Definitely better without spectacles; 2: Somewhat better without spectacles; 
3: Indifferent; 4: Somewhat better with spectacles; 5: Definitely better with spectacles.
Bother with spectacles: Do you find that it is a bother to wear spectacles? 1: No, not at all; 2: Not particularly; 3: Can’t say either way; 4: Yes, somewhat; 5: Yes, absolutely.Clinical Ophthalmology 2010:4 88
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and Spain showed ReSTOR® IOLs as being a cost-effective 
alternative to spectacles.17,34 The models were applied to data 
from clinical trials in which spectacles independence rates 
proved to be a highly sensitive parameter. However, it was 
important to confirm that the observed effectiveness in clini-
cal trials also applied to routine clinical practice.
Our study has several limitations. First, we chose the 
study centers and hence national inferences are question-
able. This was unavoidable since at the time of the survey 
ReSTOR® activities were mostly conducted at a few cen-
ters. Second, some patients declined to participate in the 
survey. The response rate was higher in France (161/194 
solicited) than Spain (163/296). Nonetheless, this rate was 
similar at all centers and no association was found between 
response rates and spectacles independence rates relative 
to centers. Third, freedom from spectacles was declared 
by the patients with no verification from other medical 
sources. This approach was taken because the question was 
simple and the answer clear to trained interviewers, who 
were independent of the ophthalmologists. Fourth, patients 
in both countries underestimated their health insurance 
coverage compared to the official data. National data for 
2006 indicate that 88.7% of the population in France35 and 
70% in Spain36 were covered by private health insurance. 
Thus it is likely that our patients were mostly retired and 
no longer had access to private insurance paid by employ-
ers. Moreover, less ubiquitous insurance coverage in Spain 
might explain why the fear of losing, damaging, or breaking 
spectacles was felt more strongly by Spanish than French 
patients. Fifth, we used a retrospective experimental design. 
While minimizing the observational bias consequences, the 
patient psychology might have been affected by the surgery 
and the association could have been different preopera-
tively. However, it has to be stated that ‘being bothered by 
spectacles’ and ‘social appearance without spectacles’ are 
personality traits that are unlikely to be modified seriously 
in 1 year. Prospective data collection should be collected 
to confirm our findings.
Conclusion
This longitudinal analysis of clinical outcomes with the 
ReSTOR® IOL confirms the results of other prospective 
clinical trials and investigations. ReSTOR® IOL implantation 
for the treatment of cataract or presbyopia conferred 
good distance and near vision, a high rate of spectacle 
independence, and considerable patient satisfaction. ‘Bother 
to wear spectacles’ and ‘self-image without spectacles’ are 
two factors associated with spectacles independence.
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